Related Experiment Video
Updated: Jun 17, 2026

08:51
Evaluation of Polymeric Gene Delivery Nanoparticles by Nanoparticle Tracking Analysis and High-throughput Flow Cytometry
Published on: March 1, 2013
PEI grafted hyperbranched polymers with polyglycerol as a core for gene delivery
Lei Zhang1, Chao-Hua Hu, Si-Xue Cheng
1Key Laboratory of Biomedical Polymers of Ministry of Education, Department of Chemistry, Wuhan University, Wuhan, Hubei 430072, PR China.
Colloids and Surfaces. B, Biointerfaces
|January 1, 2010
Summary
New hyperbranched polymers (PG6-PEI) show promise for gene delivery, offering improved transgene expression and reduced toxicity compared to traditional polymers.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Gene Therapy Vectors
Background:
- Polyethylenimines (PEIs) are widely used in gene delivery but often exhibit toxicity.
- Developing safer and more effective non-viral gene delivery vectors is crucial for therapeutic applications.
Purpose of the Study:
- To synthesize and characterize novel hyperbranched polymers, PG6-PEI25k and PG6-PEI800, by grafting polyethylenimines (PEIs) onto a polyglycerol (PG6) core.
- To evaluate the DNA binding capability, complex formation, transfection efficiency, and cytotoxicity of these new PG6-PEI polymers.
- To compare the performance of PG6-PEI polymers against their non-grafted PEI counterparts.
Main Methods:
- Synthesis of hyperbranched polymers (PG6-PEI25k, PG6-PEI800) via grafting.
- Structural characterization using 1H NMR and FTIR spectroscopy.
- DNA binding assessed by agarose gel electrophoresis retardation assay.
- Complex characterization via Transmission Electron Microscopy (TEM) and particle size analysis.
- In vitro transfection efficiency and cytotoxicity evaluated in 293T and HeLa cell lines using reporter plasmids.
Main Results:
- Successful synthesis and structural confirmation of PG6-PEI25k and PG6-PEI800.
- Demonstrated DNA binding capability for both synthesized polymers.
- Characterization of PG6-PEI/DNA complexes showing suitable morphology and size.
- PG6-PEI25k and PG6-PEI800 exhibited enhanced transgene expression compared to PEI25k and PEI800.
- Reduced cytotoxicity was observed for PG6-PEI polymers relative to PEI controls.
Conclusions:
- PG6-PEI hyperbranched polymers represent a promising class of non-viral vectors for gene delivery.
- Grafting PEI onto a polyglycerol core significantly improves transfection efficiency and reduces cytotoxicity.
- These findings highlight the potential of PG6-PEIs as effective and safer alternatives for gene therapy applications.
More Related Videos
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Transgenic Plants
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...

